According to Centers for Disease Control and Prevention, heart disease is the leading cause of death among people in United States. According to Centers for Disease Control and Prevention, in United States, one person dies every 36 seconds from cardiovascular disease. According to World Health Organization, in 2019, estimated 17.9 million people died from cardiovascular disease, representing 32% of all global deaths. According to American Heart Association, in 2017, there were 2,353 deaths from cardiovascular disease each day. According to the Centers for Disease Control and Prevention, heart disease costestimated about $219 billion each year in the United States.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-cardiac-computed-tomography-cct-market
Global cardiac computed tomography (CCT) market is expected to reach USD 2898.58 million by 2028 from USD 1831.53 million in 2020, growing at a CAGR of 6.2% in the forecast period of 2021 to 2028. Cardiovascular computed tomography is now more necessary than ever for disease diagnosis in healthcare facilities due to the increased prevalence of cardiovascular disease and rising health care costs. The market is expanding as a result of the explosion in inventions and technology as well as increased government spending. The demand for the global cardiac computed tomography (CCT) market is expected to expand over the projected period due to the rising need for diagnostic procedures brought on by an increase in the number of cardiac patients around the world and increased R&D activities.
Increasing cases of cardiovascular disease across the world will drive the market's growth rate
The increasing prevalence of cardiovascular diseases is expected to accelerate the cardiac computed tomography (CCT) market. Cardiovascular disease describes a range of conditions affecting the heart, including diseased vessels, blood clots, and structural problems. The symptoms of cardiovascular disease can vary depending upon specific conditions, including chest pain, high blood pressure, shortness of breath, nausea and vomiting, among others. The common types of cardiovascular disease include coronary heart disease and congestive heart failure. Thus, the increasing prevalence of cardiovascular diseases is a major driver for the global cardiac computed tomography (CCT) market.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2021 to 2028
|
|
Base Year
|
2020
|
|
Historic Years
|
2019 (Customizable to 2013 - 2018)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Offerings (System, Service, Software), Product Type (Single Source CT, Dual Source Cardiac CT, Spectral CT), Application (Calcium Scoring, Coronary CT Angiography, Device Implantation, Pulmonary Vein Isolation, Left Atrial Appendage Occlusion), End User (Hospitals, Speciality Centers, Diagnostic & Imaging Centers And Others) Distribution Channel (Direct Tender And Third Party Distributor)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Siemens Healthcare GmbH (Germany), Neusoft Corporation (China), Shenzhen Anke High-tech Co., Ltd. (China), Arineta (Israel), Medviso (Sweden), SinoVision (U.S.), United Imaging Healthcare Co., Ltd. (U.S.), Koninklijke Philips N.V. (Netherlands), GE Healthcare (U.S.), CANON MEDICAL SYSTEMS CORPORATION (Japan), FUJIFILM Corporation (Japan) among others.
|
|
Data Points Covered in the Report
|
In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, import/export analysis, pricing analysis, production consumption analysis, and pestle analysis.
|
Segment Analysis:
Global cardiac computed tomography (CCT) market is categorized into five notable segments which are based on offerings, product type, application, end user, and distribution channel
- On the basis of offerings, the global cardiac computed tomography (CCT) market is segmented into system, service and software. In 2021, system segment is expected to dominate the market with 81.36% due to increasing prevalence of this disease type among target population.
- On the basis of product type, the global cardiac computed tomography (CCT) marketis segmented into single source CT, dual source cardiac CT and spectral CT. In 2021, the single source CT segment is expected to dominate the market with 66.57% because of technological advancement and increasing healthcare expenditure.
- On the basis of application, the global cardiac computed tomography (CCT) marketis segmented into calcium scoring, coronary CT angiography, device implantation, pulmonary vein isolation and left atrial appendage occlusion. In 2021, calcium scoring segment expected to dominate global cardiac computed tomography (CCT) market with 33.50% market share to rising cardiovascular disease among the target population
- On the basis of end user, the global cardiac computed tomography (CCT) market is segmented into hospitals, speciality centers, diagnostic & imaging centers and others. In 2021, hospitals segment is to dominate the global cardiac computed tomography (CCT) market with 45.42% market share because of surging pool of cardiac patients.
The hospitals segment will dominate the end user segment of the cardiac computed tomography (CCT) market
The hospitals segment will emerge as the dominating segment under end user in 2021 with approximately 29% market share. This is because of the growing number of infrastructural development activities in the market, especially in the developing economies. Further, growth and expansion of the healthcare industry all around the globe will further bolster the growth of this segment.
- On the basis of distribution channel, the global cardiac computed tomography (CCT) market is segmented into direct tender and third party distributor. In 2021, direct tender segment is expected to dominate the global cardiac computed tomography (CCT) market with 86.91% market share due to the presence of large number of market players and increasing R & D activities.
The direct tender segment will dominate the distribution channel segment of the cardiac computed tomography (CCT) market
The direct tender segment will emerge as the dominating segment under the distribution channel segment in 2021. This is because of the growing number of distribution channels in the market especially in the developing economies. Further, growth and expansion of research development services on a global scale will further bolster the growth of this segment.
Major Players
Data Bridge Market Research recognizes the following companies as the market players in cardiac computed tomography (CCT) market: Siemens Healthcare GmbH (Germany), Neusoft Corporation (China), Shenzhen Anke High-tech Co., Ltd. (China), Arineta (Israel), Medviso (Sweden), SinoVision (U.S.), United Imaging Healthcare Co., Ltd. (U.S.), Koninklijke Philips N.V. (Netherlands), GE Healthcare (U.S.), CANON MEDICAL SYSTEMS CORPORATION (Japan) and FUJIFILM Corporation (Japan).
Market Development
- In May 2021, Koninklijke Philips N.V. announced the Spectral Computed Tomography 7500 system launch. The system delivers high quality spectral images for every patient for every scan. This will help the company expand its business and strengthen its product profile.
- In February 2019, CANON MEDICAL SYSTEMS CORPORATION (A Subsidiary Of Canon Inc.) announced that they have expanded their CT radiation oncology product portfolio by launching the Aquilion Prime SP and Aquilion Lightning 80. This advanced product has a cost-effective solution that increases the usage, efficiency, and workflow. After launching the new products, the company has enhanced their product portfolio and generates adequate revenue in the market.
Regional Analysis
Geographically, the countries covered in the cardiac computed tomography (CCT) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis:
North America is the dominant region in cardiac computed tomography (CCT) market during the forecast period 2021 - 2028
In 2021, North America had the greatest market share and it is anticipated that it would maintain its dominance during the projection period. Two major variables influencing the growth of the regional market are the high number of market competitors in this area and the rising incidence rate of cancer. The National Cancer Institute estimates that 1,806,590 new cancer cases will be discovered in the United States in 2020. Additionally, it is anticipated that the regular release of low radiation CT scans and the introduction of new technologies paired with artificial intelligence would contribute to market expansion.
Asia-Pacific is estimated to be the fastest-growing region in cardiac computed tomography (CCT) market the forecast period 2021 - 2028
Due to the region's rapidly expanding economies, particularly those of China and India, as well as the region's expanding healthcare infrastructure, the market for advanced medical imaging equipment is expected to grow at a strong CAGR in Asia Pacific over the course of the forecast period. Additionally, expanding local producers and the rising frequency of chronic diseases are anticipated to support market expansion. For instance, Siemens Healthineers opened a new CT scanner production facility in India to meet the rising demand for the devices and strengthen its position in the market.
COVID-19 Impact
Increased incidences of lung cancer, breast cancer, head cancer, communicable diseases like COVID-19, rising demand for computed tomography scans to detect infection, and increased use of computed tomography scans to evaluate the efficacy of treatments are the main factors driving the global cardiac computed tomography (CT) market's growth. The need for CT scanners has increased as a result of the rising COVID-19 cases, which is anticipated to have a favorable effect on the CT industry. For instance, a 16-slice mobile CT scanner was introduced by the Abu Dhabi Health Services Company (SEHA) in the United Arab Emirates in June 2020 to diagnose pneumonia in COVID-19 patients, demonstrating that underdeveloped nations are adopting CT scanners to find COVID-19. According to a June 2020 paper titled "Chest CT characteristics and their relevance in COVID-19," CT imaging was a crucial auxiliary tool in diagnosing and treating COVID-19 patients.
For more detailed information about the cardiac computed tomography (CCT) on market report, click here – https://www.databridgemarketresearch.com/reports/global-cardiac-computed-tomography-cct-market
